142 related articles for article (PubMed ID: 16261551)
1. Design, synthesis and analysis of inhibitors of bacterial aspartate semialdehyde dehydrogenase.
Cox RJ; Gibson JS; Hadfield AT
Chembiochem; 2005 Dec; 6(12):2255-60. PubMed ID: 16261551
[TBL] [Abstract][Full Text] [Related]
2. Aspartyl phosphonates and phosphoramidates: the first synthetic inhibitors of bacterial aspartate-semialdehyde dehydrogenase.
Cox RJ; Gibson JS; Mayo Martín MB
Chembiochem; 2002 Sep; 3(9):874-86. PubMed ID: 12210989
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of conformationally restricted inhibitors of aspartate semialdehyde dehydrogenase.
Evitt AS; Cox RJ
Mol Biosyst; 2011 May; 7(5):1564-75. PubMed ID: 21369577
[TBL] [Abstract][Full Text] [Related]
4. Structural basis for discrimination between oxyanion substrates or inhibitors in aspartate-beta-semialdehyde dehydrogenase.
Faehnle CR; Blanco J; Viola RE
Acta Crystallogr D Biol Crystallogr; 2004 Dec; 60(Pt 12 Pt 2):2320-4. PubMed ID: 15583380
[TBL] [Abstract][Full Text] [Related]
5. The role of substrate-binding groups in the mechanism of aspartate-beta-semialdehyde dehydrogenase.
Blanco J; Moore RA; Faehnle CR; Coe DM; Viola RE
Acta Crystallogr D Biol Crystallogr; 2004 Aug; 60(Pt 8):1388-95. PubMed ID: 15272161
[TBL] [Abstract][Full Text] [Related]
6. Difluoromethylene analogues of aspartyl phosphate: the first synthetic inhibitors of aspartate semi-aldehyde dehydrogenase.
Cox RJ; Hadfield AT; Mayo-Martín MB
Chem Commun (Camb); 2001 Sep; (18):1710-1. PubMed ID: 12240277
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and activity of bisubstrate, transition-state analogues and competitive inhibitors of aspartate transcarbamylase.
Grison C; Coutrot P; Comoy C; Balas L; Joliez S; Lavecchia G; Oliger P; Penverne B; Serre V; Hervé G
Eur J Med Chem; 2004 Apr; 39(4):333-44. PubMed ID: 15072842
[TBL] [Abstract][Full Text] [Related]
8. Mapping the aspartic acid binding site of Escherichia coli asparagine synthetase B using substrate analogs.
Parr IB; Boehlein SK; Dribben AB; Schuster SM; Richards NG
J Med Chem; 1996 Jun; 39(12):2367-78. PubMed ID: 8691431
[TBL] [Abstract][Full Text] [Related]
9. Shape-based virtual screening, docking, and molecular dynamics simulations to identify Mtb-ASADH inhibitors.
Kumar R; Garg P; Bharatam PV
J Biomol Struct Dyn; 2015; 33(5):1082-93. PubMed ID: 24875451
[TBL] [Abstract][Full Text] [Related]
10. Elaboration of a fragment library hit produces potent and selective aspartate semialdehyde dehydrogenase inhibitors.
Thangavelu B; Bhansali P; Viola RE
Bioorg Med Chem; 2015 Oct; 23(20):6622-31. PubMed ID: 26404410
[TBL] [Abstract][Full Text] [Related]
11. T-state inhibitors of E. coli aspartate transcarbamoylase that prevent the allosteric transition.
Heng S; Stieglitz KA; Eldo J; Xia J; Cardia JP; Kantrowitz ER
Biochemistry; 2006 Aug; 45(33):10062-71. PubMed ID: 16906764
[TBL] [Abstract][Full Text] [Related]
12. Expression and purification of aspartate beta-semialdehyde dehydrogenase from infectious microorganisms.
Moore RA; Bocik WE; Viola RE
Protein Expr Purif; 2002 Jun; 25(1):189-94. PubMed ID: 12071715
[TBL] [Abstract][Full Text] [Related]
13. A new synthesis of phosphoramidates: inhibitors of the key bacterial enzyme aspartate semi-aldehyde dehydrogenase.
Adams LA; Cox RJ; Gibson JS; Mayo-Martín MB; Walter M; Whittingham W
Chem Commun (Camb); 2002 Sep; (18):2004-5. PubMed ID: 12357751
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and evaluation of gamma-phosphono diester analogues of glutamate as highly potent inhibitors and active site probes of gamma-glutamyl transpeptidase.
Han L; Hiratake J; Kamiyama A; Sakata K
Biochemistry; 2007 Feb; 46(5):1432-47. PubMed ID: 17260973
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of mandelate racemase by the substrate-intermediate-product analogue 1,1-diphenyl-1-hydroxymethylphosphonate.
Burley RK; Bearne SL
Bioorg Med Chem Lett; 2005 Oct; 15(19):4342-4. PubMed ID: 16039120
[TBL] [Abstract][Full Text] [Related]
16. [Aspartyladenylate analog--effective inhibitor of asparagine synthetase].
Zhukov IuN; Biriukov AI; Khomutov RM
Bioorg Khim; 1988 Jul; 14(7):969-72. PubMed ID: 2903747
[TBL] [Abstract][Full Text] [Related]
17. A cautionary tale of structure-guided inhibitor development against an essential enzyme in the aspartate-biosynthetic pathway.
Pavlovsky AG; Thangavelu B; Bhansali P; Viola RE
Acta Crystallogr D Biol Crystallogr; 2014 Dec; 70(Pt 12):3244-52. PubMed ID: 25478842
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and aminoacyl-tRNA synthetase inhibitory activity of aspartyl adenylate analogs.
Bernier S; Akochy PM; Lapointe J; Chênevert R
Bioorg Med Chem; 2005 Jan; 13(1):69-75. PubMed ID: 15582453
[TBL] [Abstract][Full Text] [Related]
19. Use of structural comparisons to select mutagenic targets in aspartate-beta-semialdehyde dehydrogenase.
Ouyang J; Viola RE
Biochemistry; 1995 May; 34(19):6394-9. PubMed ID: 7756269
[TBL] [Abstract][Full Text] [Related]
20. Two new irreversible inhibitors of dihydrodipicolinate synthase: diethyl (E,E)-4-oxo-2,5-heptadienedioate and diethyl (E)-4-oxo-2-heptenedioate.
Turner JJ; Healy JP; Dobson RC; Gerrard JA; Hutton CA
Bioorg Med Chem Lett; 2005 Feb; 15(4):995-8. PubMed ID: 15686899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
